CTSI - CABG Minimally Invasive Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTSI - CABG Minimally Invasive

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pierre Borczuk who wrote (10)	9/27/1996 4:17:00 PM
From: Robert Salasidis	of 29

I had bought all the shares I wanted in this stock back at 22 before the drop. I probably should have bought more when it was in the low teens but didn't. At this point I decided I have enough for a run to wherever it goes (this being one of my speculative stocks - I don't like to average down on those). My feeling is that if another major HMO or hospital is reported to be using their system, the stock could have another short term run. I still feel that a major run to the 50+ range would require a controlled trial showing improved survival with this bypass technique vs angioplasty for single vessel disease - I have not heard of a study like this having even been started though. The procedure can be performed with a mortality rate that is <1%, and should have a patency rate that exceeds that of PTCA (10 vs 1-3 yrs). Since the PTCA group would eventually need repeat procedures, or a formal bypass, it is not inconceivable that this procedure could be a select replacement for LAD PTCA. If I ever call the company I will inquire about this.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next